Strattera has a new bolded warning about severe liver injury
February 2005
Strattera has a new bolded warning about severe liver injury.
This is because of two new reports of extremely elevated liver enzymes...in a teen and an adult taking Strattera (atomoxetine) for attention deficit hyperactivity disorder (ADHD).
The enzymes increased several months into treatment...and normalized after stopping Strattera.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote